{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}],"title":"Number of participants with complications secondary to cold plasma application"},{"measurements":[{"groupId":"OG000","value":"20"}],"title":"Number of patients receiving cold plasma application."}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Adverse events (CTCAE event version 4.03 to 5.0) within 30 days after Canady Helios Cold Plasma Scalpel treatment.","groups":[{"description":"After the gross solid tumor is removed, cold plasma is sprayed in the area of the resected tumor margins.\n\nCanady Helios Cold Plasma Scalpel: Device used to distribute cold plasma energy at the resected tumor margins.\n\nPost-operatively, patients will be started back on Adjuvant chemotherapy, radiation, or immuno-therapy as per medical oncology and multi-disciplinary team.","id":"OG000","title":"Primary Arm"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Immediate after application of cold plasma, followed by 3 months, 6 months, 12 months and 15 month observations.","title":"Number of Participants With Complications Due To Cold Plasma Application","type":"PRIMARY","unitOfMeasure":"Participants"}